Yan Zhang

Yan Zhang is an Associate Professor in the Department of Biological Chemistry at the University of Michigan Medical School, where they lead pioneering research on CRISPR gene editing systems. Their laboratory focuses on developing and refining CRISPR-based genome editing tools, with particular emphasis on Type I CRISPR systems and the Cas3 nuclease.

Dr. Zhang's research interests center on molecular mechanisms of CRISPR systems, particularly the development of compact CRISPR-Cas3 platforms for therapeutic applications. Their work has significantly advanced the understanding of how CRISPR systems can be engineered for precise genome editing, with implications for treating genetic diseases, cancer, and developing novel biotechnological tools. They have made key contributions to understanding off-switch mechanisms for CRISPR-Cas3, enabling safer and more controlled genome editing applications.

Analysis of Dr. Zhang's publication record reveals a strong focus on translating basic CRISPR research into practical applications. Their work spans from fundamental molecular mechanisms of CRISPR systems to therapeutic applications in human cells, with particular emphasis on developing compact CRISPR systems that can make large DNA deletions. This research trajectory demonstrates a clear progression from basic science to translational applications, with increasing focus on therapeutic relevance in recent years.

• Significant media coverage across 29+ news outlets for CRISPR-Cas3 research
• Highlighted in Faculty Opinions Research
• Multiple high-impact publications in Molecular Cell, Frontiers in Microbiology, and other prestigious journals

Dr. Zhang actively mentors graduate students and postdoctoral researchers, with notable advisees including Renke Tan (who completed PhD work on CRISPR-Cas3 systems) and Zhonggang Hou. Their research has been supported by multiple grants at the University of Michigan, resulting in 34 publications and 10 patents. The Zhang laboratory collaborates extensively with researchers across disciplines, including microbiologists, biochemists, and medical researchers, to advance CRISPR technology for biomedical applications.

The Zhang laboratory is at the forefront of CRISPR-Cas3 research, working to develop safer and more efficient genome editing tools. Their current work focuses on refining off-switch mechanisms for CRISPR systems and developing applications for cancer treatment and genetic disease correction. The lab maintains strong collaborations with other research groups at the University of Michigan and beyond, forming a vibrant research community focused on advancing genome editing technology.